Works matching IS 1007385X AND DT 2022 AND VI 29 AND IP 9

Results: 12

Immunocheckpoint inhibitor combined with endocrine therapy for simultaneous prostate cancer and lung squamous cell carcinoma:two case reports and literature reviews.

Published in:: Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 856, doi. 10.3872/j.issn.1007-385x.2022.09.012
Publication type:: Article

Research progress in the role of absent in belanoma 2 in cancer pathogenesis and development.

Published in:: Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 851, doi. 10.3872/j.issn.1007-385x.2022.09.011
Publication type:: Article

Research progress in the role and mechanism of MMP-9 in the metastasis of non-small cell lung cancer.

Published in:: Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 846, doi. 10.3872/j.issn.1007-385x.2022.09.010
Publication type:: Article

Research progress on pathogenesis and immunotargeted therapy of EBV-related tumors.

Published in:: Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 840, doi. 10.3872/j.issn.1007-385x.2022.09.009
Publication type:: Article

Research progress in CAR-T cell therapies targeting tumor microenvironment in colorectal cancers.

Published in:: Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 834, doi. 10.3872/j.issn.1007-385x.2022.09.008
Publication type:: Article

Efficacy and safety of pembrolizumab plus albumin-bound paclitaxel and nedaplatin as a first-line therapy for advanced esophageal squamous cell carcinoma.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 828, doi. 10.3872/j.issn.1007-385x.2022.09.007

By:

YAN Fang;
YING Mingzhen;
CHEN Longpei;
HUANG Jingyi;
FU Qiang

Publication type:

Article

Expression characteristics and clinical significance of HHLA2 and its receptor TMIGD2 in ovarian cancer tissues.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 822, doi. 10.3872/j.issn.1007-385x.2022.09.006

By:

FU Yuanyuan;
ZHENG Panpan;
KONG Caixia;
PAN Yunyan;
JIANG Jingting

Publication type:

Article

Expression and clinical significance of E3 ubiquitin ligase HECW2 in gastric adenocarcinoma tissues.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 813, doi. 10.3872/j.issn.1007-385x.2022.09.005

By:

LI Fang;
SHEN Hui;
WANG Xiaofei;
WANG Li;
HAN Caili;
LIU Junli;
ZHANG Jing

Publication type:

Article

Ethanol extract from Euphorbia humifusa inhibits the malignant biological behaviors of colorectal cancer SW480 cells by regulating the circRHOT1/miR-29a-3p molecular axis.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 806, doi. 10.3872/j.issn.1007-385x.2022.09.004

By:

FAN Hongge;
DAI Weibo;
ZHANG Xuefeng

Publication type:

Article

The mechanism and relative significance of carboxypeptidase A4 promoting the proliferation, migration, invasion and EMT of non-small cell lung cancer cells.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 797, doi. 10.3872/j.issn.1007-385x.2022.09.003

By:

TONG Anna;
YAN Peng

Publication type:

Article

The treatment of multiple myeloma by CAR-T cells: the problems and countermeasures.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 791, doi. 10.3872/j.issn.1007-385x.2022.09.002

By:

ZHANG Jing;
WANG Jianxun

Publication type:

Article

Immune cell therapies for solid tumors: an overview of challenges and counter measures.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 9, p. 781, doi. 10.3872/j.issn.1007-385x.2022.09.001

By:

LIU Shasha;
TIAN Yonggui;
ZHANG Yi

Publication type:

Article